SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

MiniMed Group, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

60365F109

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

60365F109

Names of Reporting Persons

Medtronic plc

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

IRELAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 252,813,348.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 252,813,348.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

252,813,348.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

90.0 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person: Number of shares beneficially owned reported in Rows 5 and 7 consists of shares held of record by Medtronic Global Holdings S.C.A., an indirect, wholly-owned subsidiary of Medtronic plc. Percentage reported in Row 11 is based on 280,819,988 shares of common stock outstanding as of April 11, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on April 17, 2026.

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

MiniMed Group, Inc.

(b)

Address of issuer's principal executive offices:

18000 Devonshire Street, Northridge, CA 91325

Item 2.

(a)

Name of person filing:

Medtronic plc

(b)

Address or principal business office or, if none, residence:

Building Two, Parkmore Business Park West, Galway, Ireland H91 4K49

(c)

Citizenship:

(d)

Title of class of securities:

Common Stock, par value $0.01 per share

(e)

CUSIP Number(s):

60365F109

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

252,813,348

(b)

Percent of class:

90.0%

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

252,813,348

(ii) Shared power to vote or to direct the vote:

(iii) Sole power to dispose or to direct the disposition of:

252,813,348

(iv) Shared power to dispose or to direct the disposition of:

Item 5.

Ownership of 5 Percent or Less of a Class.

Not Applicable

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Medtronic plc

Signature:	/s/ Brian Sandstrom
Name/Title:	Brian Sandstrom/VP, Chief Corporate and Securities Counsel
Date:	05/06/2026

SEC Form SCHEDULE 13G filed by MiniMed Group Inc.